Glucocorticoid-induced bone disease is characterized by decreased bone formation and in situ death of isolated segments of bone (osteonecrosis) suggesting that glucocorticoid excess, the third most common cause of osteoporosis, may affect the birth or death rate of bone cells, thus reducing their numbers. To test this hypothesis, we administered prednisolone to 7-mo-old mice for 27 d and found decreased bone density, serum osteocalcin, and cancellous bone area along with trabecular narrowing. These changes were accompanied by diminished bone formation and turnover, as determined by histomorphometric analysis of tetracycline-labeled vertebrae, and impaired osteoblastogenesis and osteoclastogenesis, as determined by ex vivo bone marrow cell cultures. In addition, the mice exhibited a threefold increase in osteoblast apoptosis in vertebrae and showed apoptosis in 28% of the osteocytes in metaphyseal cortical bone. As in mice, an increase in osteoblast and osteocyte apoptosis was documented in patients with glucocorticoid-induced osteoporosis. Decreased production of osteoclasts explains the reduction in bone turnover, whereas decreased production and apoptosis of osteoblasts would account for the decline in bone formation and trabecular width. Furthermore, accumulation of apoptotic osteocytes may contribute to osteonecrosis. These findings provide evidence that glucocorticoid-induced bone disease arises from changes in the numbers of bone cells.
R S Weinstein, R L Jilka, A M Parfitt, S C Manolagas
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1995 | 1992 | 1991 | 1988 | 1974 | 1968 | 1966 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 6 | 22 | 28 | 34 | 52 | 51 | 45 | 53 | 57 | 62 | 49 | 55 | 53 | 68 | 69 | 56 | 63 | 46 | 55 | 52 | 52 | 33 | 50 | 42 | 40 | 37 | 11 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1252 |
Title and authors | Publication | Year |
---|---|---|
Sexual dimorphism and age dependence of osteocyte lacunar density for human vertebral cancellous bone
D Vashishth, GJ Gibson, DP Fyhrie |
The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology | 2005 |
Glucocorticoid-Treated Mice Have Localized Changes in Trabecular Bone Material Properties and Osteocyte Lacunar Size That Are Not Observed in Placebo-Treated or Estrogen-Deficient Mice
NE Lane, W Yao, M Balooch, RK Nalla, G Balooch, S Habelitz, JH Kinney, LF Bonewald |
Journal of Bone and Mineral Research | 2005 |
Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
S Akahoshi, A Sakai, S Arita, S Ikeda, Y Morishita, H Tsutsumi, M Ito, A Shiraishi, T Nakamura |
Journal of Bone and Mineral Metabolism | 2005 |
Mechanisms of glucocorticoid action in bone
E Canalis |
Current Osteoporosis Reports | 2005 |
Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects
S Alesci, MU de Martino, I Ilias, PW Gold, GP Chrousos |
Neuroimmunomodulation | 2005 |
Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus
V Lilleby, G Lien, KF Frøslie, M Haugen, B Flatø, ØY Førre |
Arthritis & Rheumatism | 2005 |
Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS) patients in Hong Kong
EM Lau, FW Chan, DS Hui, AK Wu, PC Leung |
Bone | 2005 |
New and improved glucocorticoid receptor ligands
JN Miner, MH Hong, A Negro-Vilar |
Expert Opinion on Investigational Drugs | 2005 |
A Controlled Study of Vitamin D3 to Prevent Bone Loss in Renal-Transplant Patients Receiving Low Doses of Steroids
KM Wissing, N Broeders, R Moreno-Reyes, C Gervy, B Stallenberg, D Abramowicz |
Transplantation | 2005 |
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce |
Biochemical and Biophysical Research Communications | 2005 |
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis
G Gu, TA Hentunen, M Nars, PL Härkönen, HK Väänänen |
Apoptosis | 2005 |
Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: Presence of glucocorticoid receptor alpha in mitochondria and of glucocorticoid receptor beta in nucleoli
AM Psarra, S Solakidi, IP Trougakos, LH Margaritis, G Spyrou, CE Sekeris |
The International Journal of Biochemistry & Cell Biology | 2005 |
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club
JP Devogelaer, S Goemaere, S Boonen, JJ Body, JM Kaufman, JY Reginster, S Rozenberg, Y Boutsen |
Osteoporosis International | 2005 |
Glucocorticoid-induced osteoporosis: Treatment options and guidelines
M Maricic |
Current Osteoporosis Reports | 2005 |
In whom and how to prevent glucocorticoid-induced osteoporosis
JD Adachi, A Papaioannou |
Best Practice & Research Clinical Rheumatology | 2005 |
Apoptosis in glucocorticoid-induced bone disease
RS Weinstein, SC Manolagas |
Current Opinion in Internal Medicine | 2005 |
Osteoporosis in Systemic Lupus Erythematosus Mechanisms
C Lee, R Ramsey-Goldman |
Rheumatic Disease Clinics of North America | 2005 |
Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep
S Schorlemmer, A Ignatius, L Claes, P Augat |
Bone | 2005 |
Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption
G Gu, M Mulari, Z Peng, TA Hentunen, HK Väänänen |
Biochemical and Biophysical Research Communications | 2005 |
The management of secondary osteoporosis
A Kelman, NE Lane |
Best Practice & Research Clinical Rheumatology | 2005 |
Caffeine-mediated enhancement of glucocorticoid receptor activity in human osteoblastic cells
M Föcking, D Schmiegelt, T Trapp |
Biochemical and Biophysical Research Communications | 2005 |
Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer
N Leclerc, T Noh, A Khokhar, E Smith, B Frenkel |
Arthritis & Rheumatism | 2005 |
Osteoporosis due to Glucocorticoid Use in Children with Chronic Illness
LM Ward |
Hormone Research | 2005 |
Inhaled corticosteroids and risk of osteoporosis in asthma - reply
S Boonen, D Vanderschueren, W Lauriks, JP Devogelaer |
Journal of Internal Medicine | 2005 |
Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: Comparison of megadose methylprednisolone and conventional-dose prednisolone treatments
A Alikasifoglu, S Yetgin, M Cetin, M Tuncer, F Gumruk, A Gurgey, N Yordam |
American Journal of Hematology | 2005 |
Low Pretransplant Bone-Mineral Density and Rapid Bone Loss Do Not Increase Risk for Avascular Osteonecrosis after Allogeneic Hematopoietic Stem Cell Transplantation
CM Schulte, DW Beelen |
Transplantation | 2005 |
A Histomorphometric Study of Cortical Bone of the Iliac Crest in Patients Treated with Glucocorticoids
S Vedi, SL Elkin, JE Compston |
Calcified Tissue International | 2005 |
Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus
JM Campistol, DW Holt, S Epstein, M Gioud-Paquet, K Rutault, JT Burke |
Transplant International | 2005 |
Childhood Cancer Survivors
CT Chollet, L Britton, MD Neel, MM Hudson, SC Kaste |
Clinical Orthopaedics and Related Research | 2005 |
Changes in Bone Mineral Density and Selected Metabolic Parameters Over 24 Months Following Renal Transplantation
S Al-Gabri, J Zadražil, K Krejčı́, P Horák, P Bachleda |
Transplantation Proceedings | 2005 |
Use of Oral Corticosteroids and Risk of Fractures
TP van Staa, HG Leufkens, L Abenhaim, B Zhang, C Cooper |
Journal of Bone and Mineral Research | 2005 |
Disorders of Calcium and Phosphorus Metabolism
LP Rubin |
Avery s Diseases of the Newborn | 2005 |
11β-HSD: Guardian or gate crasher?
RS Weinstein |
BoneKEy-Osteovision | 2005 |
Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements
S Gulati, RK Sharma, K Gulati, U Singh, A Srivastava |
Nephrology Dialysis Transplantation | 2005 |
Bone Disease of Organ Transplantation
MR Rubin, JP Billezkian |
Bone Disease of Organ Transplantation | 2005 |
Osteoporosis Associated with Excess Glucocorticoids
JL Shaker, BP Lukert |
Endocrinology and metabolism clinics of North America | 2005 |
The Bone and Mineral Manual
BP Lukert |
The Bone and Mineral Manual | 2005 |
Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells
MF Iu, H Kaji, J Naito, H Sowa, T Sugimoto, K Chihara |
Journal of Bone and Mineral Metabolism | 2005 |
Osteoporosis secundaria a tratamiento con glucocorticoides
J Escalada |
Endocrinología y Nutrición | 2005 |
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study
C Kristo, R Jemtland, T Ueland, K Godang, J Bollerslev |
European Journal of Endocrinology | 2005 |
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects
S Bonadonna, A Burattin, M Nuzzo, G Bugari, EA Rosei, D Valle, N Iori, JP Bilezikian, JD Veldhuis, A Giustina |
European Journal of Endocrinology | 2005 |
Avascular Necrosis of Femoral and/or Humeral Heads in Multiple Myeloma: Results of a Prospective Study of Patients Treated With Dexamethasone-Based Regimens and High-Dose Chemotherapy
G Talamo, E Angtuaco, RC Walker, L Dong, MH Miceli, M Zangari, G Tricot, B Barlogie, E Anaissie |
Journal of Clinical Oncology | 2005 |
Osteoporose após transplante de órgãos sólidos
R Cipriani, ML Farias |
Arquivos brasileiros de endocrinologia e metabologia | 2005 |
High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients
VZ Borba, PG Matos, PR da Viana, A Fernandes, EI Sato, M Lazaretti-Castro |
Lupus | 2005 |
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
LI Plotkin, I Mathov, JI Aguirre, AM Parfitt, SC Manolagas, T Bellido |
American journal of physiology. Cell physiology | 2005 |
Effects of disrupted β 1 -integrin function on the skeletal response to short-term hindlimb unloading in mice
UT Iwaniec, TJ Wronski, D Amblard, Y Nishimura, MC van der Meulen, CE Wade, MA Bourgeois, CD Damsky, RK Globus |
Journal of applied physiology | 2005 |
IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice
CA O'Brien, RL Jilka, Q Fu, S Stewart, RS Weinstein, SC Manolagas |
American journal of physiology. Endocrinology and metabolism | 2005 |
PLEYOTROPNYE EFFEKTY D-GORMONA (AL'FAKAL'TsIDOLA) NA KOSTI, MYShTsY, KIShEChNIK I IMMUNNUYu SISTEMU. Lektsiya
SK Sharla |
Osteoporosis and osteopathy | 2005 |
L’osteoporosi indotta da corticosteroidi: Fisiopatologia, prevenzione e trattamento
OD Munno, M Varenna, AD Sedie, S Casari, L Sinigaglia |
L'Endocrinologo | 2005 |
Bone Resorption
F Bronner, MC Farach-Carson, J Rubin |
2005 | |
11β-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation
M Eijken, M Hewison, MS Cooper, FH de Jong, H Chiba, PM Stewart, AG Uitterlinden, HA Pols, JP van Leeuwen |
Molecular Endocrinology | 2005 |
Vasculature deprivation – induced osteonecrosis of the rat femoral head as a model for therapeutic trials
J Bejar, E Peled, JH Boss |
Theoretical Biology and Medical Modelling | 2005 |